{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Dépistage multiple : Questions médicales les plus fréquentes",
"headline": "Dépistage multiple : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Dépistage multiple : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-11",
"dateModified": "2025-04-05",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Dépistage multiple"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Dépistage de masse",
"url": "https://questionsmedicales.fr/mesh/D008403",
"about": {
"@type": "MedicalCondition",
"name": "Dépistage de masse",
"code": {
"@type": "MedicalCode",
"code": "D008403",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.780.500"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Dépistage multiple",
"alternateName": "Multiphasic Screening",
"code": {
"@type": "MedicalCode",
"code": "D009098",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Dihao Wang",
"url": "https://questionsmedicales.fr/author/Dihao%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Physics, The Ohio State University, Columbus, OH 43210."
}
},
{
"@type": "Person",
"name": "Xiankun Li",
"url": "https://questionsmedicales.fr/author/Xiankun%20Li",
"affiliation": {
"@type": "Organization",
"name": "Department of Physics, The Ohio State University, Columbus, OH 43210."
}
},
{
"@type": "Person",
"name": "Lijuan Wang",
"url": "https://questionsmedicales.fr/author/Lijuan%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Physics, The Ohio State University, Columbus, OH 43210."
}
},
{
"@type": "Person",
"name": "Xiaojing Yang",
"url": "https://questionsmedicales.fr/author/Xiaojing%20Yang",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Illinois at Chicago, Chicago, IL 60607."
}
},
{
"@type": "Person",
"name": "Dongping Zhong",
"url": "https://questionsmedicales.fr/author/Dongping%20Zhong",
"affiliation": {
"@type": "Organization",
"name": "Department of Physics, The Ohio State University, Columbus, OH 43210; zhong.28@osu.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Methicillin-resistant Staphylococcus aureus-associated orbital cellulitis: a case series.",
"datePublished": "2023-04-07",
"url": "https://questionsmedicales.fr/article/37029211",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10792-023-02698-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mptx2 defends against peritoneal infection by methicillin-resistant staphylococcus aureus.",
"datePublished": "2022-05-21",
"url": "https://questionsmedicales.fr/article/35609377",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.intimp.2022.108856"
}
},
{
"@type": "ScholarlyArticle",
"name": "Predictors of Methicillin-resistant Staphylococcus aureus infection in children with acute osteomyelitis.",
"datePublished": "2024-10-10",
"url": "https://questionsmedicales.fr/article/39390563",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13052-024-01780-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Prevalence and risk factors for methicillin-resistant Staphylococcus aureus infection in children].",
"datePublished": "2024-01-22",
"url": "https://questionsmedicales.fr/article/38245868",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.37201/req/113.2023"
}
},
{
"@type": "ScholarlyArticle",
"name": "Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia.",
"datePublished": "2022-11-21",
"url": "https://questionsmedicales.fr/article/36371648",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/phar.2741"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Santé publique",
"item": "https://questionsmedicales.fr/mesh/D011634"
},
{
"@type": "ListItem",
"position": 4,
"name": "Pratiques en santé publique",
"item": "https://questionsmedicales.fr/mesh/D015980"
},
{
"@type": "ListItem",
"position": 5,
"name": "Dépistage de masse",
"item": "https://questionsmedicales.fr/mesh/D008403"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dépistage multiple",
"item": "https://questionsmedicales.fr/mesh/D009098"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Dépistage multiple - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Dépistage multiple",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Dépistage multiple",
"description": "Qu'est-ce que le dépistage multiple ?\nQuels tests sont inclus dans le dépistage multiple ?\nComment le dépistage multiple est-il réalisé ?\nQui peut bénéficier du dépistage multiple ?\nLe dépistage multiple est-il efficace ?",
"url": "https://questionsmedicales.fr/mesh/D009098?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Dépistage multiple",
"description": "Quels symptômes peuvent être détectés par dépistage ?\nLe dépistage multiple peut-il révéler des maladies asymptomatiques ?\nComment les symptômes influencent-ils le dépistage ?\nLes symptômes sont-ils toujours présents lors du dépistage ?\nQuels symptômes nécessitent un dépistage urgent ?",
"url": "https://questionsmedicales.fr/mesh/D009098?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Dépistage multiple",
"description": "Comment le dépistage multiple contribue-t-il à la prévention ?\nLe dépistage multiple est-il recommandé pour tous ?\nÀ quelle fréquence doit-on se soumettre à un dépistage multiple ?\nLe dépistage multiple peut-il prévenir des maladies graves ?\nQuels modes de vie favorisent un dépistage efficace ?",
"url": "https://questionsmedicales.fr/mesh/D009098?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Dépistage multiple",
"description": "Quels traitements suivent un dépistage positif ?\nLe dépistage multiple influence-t-il le traitement ?\nComment le dépistage multiple aide-t-il au suivi des traitements ?\nLes traitements sont-ils standardisés après un dépistage ?\nLe dépistage multiple peut-il réduire les coûts de traitement ?",
"url": "https://questionsmedicales.fr/mesh/D009098?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Dépistage multiple",
"description": "Quelles complications peuvent survenir sans dépistage ?\nLe dépistage multiple peut-il réduire les complications ?\nQuelles complications sont souvent évitées par le dépistage ?\nLe dépistage multiple peut-il entraîner des complications ?\nComment gérer les complications après un dépistage ?",
"url": "https://questionsmedicales.fr/mesh/D009098?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Dépistage multiple",
"description": "Quels sont les facteurs de risque pour le dépistage multiple ?\nComment les facteurs de risque influencent-ils le dépistage ?\nLes facteurs de risque sont-ils les mêmes pour tous ?\nPeut-on modifier les facteurs de risque ?\nComment évaluer ses facteurs de risque ?",
"url": "https://questionsmedicales.fr/mesh/D009098?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Qu'est-ce que le dépistage multiple ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est une évaluation simultanée de plusieurs maladies pour un diagnostic précoce."
}
},
{
"@type": "Question",
"name": "Quels tests sont inclus dans le dépistage multiple ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut inclure des analyses sanguines, des examens d'imagerie et des tests fonctionnels."
}
},
{
"@type": "Question",
"name": "Comment le dépistage multiple est-il réalisé ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est effectué lors d'une consultation médicale, souvent en une seule visite."
}
},
{
"@type": "Question",
"name": "Qui peut bénéficier du dépistage multiple ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les adultes, en particulier ceux à risque accru de maladies chroniques, peuvent en bénéficier."
}
},
{
"@type": "Question",
"name": "Le dépistage multiple est-il efficace ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il permet de détecter plusieurs maladies à un stade précoce, améliorant les résultats."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent être détectés par dépistage ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes de maladies comme le diabète, l'hypertension ou le cancer peuvent être identifiés."
}
},
{
"@type": "Question",
"name": "Le dépistage multiple peut-il révéler des maladies asymptomatiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut détecter des maladies sans symptômes apparents, comme certains cancers."
}
},
{
"@type": "Question",
"name": "Comment les symptômes influencent-ils le dépistage ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "La présence de symptômes peut orienter le choix des tests à réaliser lors du dépistage."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents lors du dépistage ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, le dépistage peut identifier des maladies avant l'apparition de symptômes."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent un dépistage urgent ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme une perte de poids inexpliquée ou des douleurs persistantes doivent être évalués."
}
},
{
"@type": "Question",
"name": "Comment le dépistage multiple contribue-t-il à la prévention ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il permet de détecter des maladies à un stade précoce, facilitant des interventions préventives."
}
},
{
"@type": "Question",
"name": "Le dépistage multiple est-il recommandé pour tous ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, il est recommandé en fonction des facteurs de risque individuels et de l'âge."
}
},
{
"@type": "Question",
"name": "À quelle fréquence doit-on se soumettre à un dépistage multiple ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La fréquence dépend des recommandations médicales et des antécédents de santé."
}
},
{
"@type": "Question",
"name": "Le dépistage multiple peut-il prévenir des maladies graves ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut prévenir des maladies graves en permettant un traitement précoce."
}
},
{
"@type": "Question",
"name": "Quels modes de vie favorisent un dépistage efficace ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, favorise le dépistage."
}
},
{
"@type": "Question",
"name": "Quels traitements suivent un dépistage positif ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements peuvent inclure des médicaments, des interventions chirurgicales ou des thérapies."
}
},
{
"@type": "Question",
"name": "Le dépistage multiple influence-t-il le traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il permet d'adapter le traitement en fonction des maladies détectées simultanément."
}
},
{
"@type": "Question",
"name": "Comment le dépistage multiple aide-t-il au suivi des traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il permet de surveiller l'évolution de plusieurs conditions de santé en même temps."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils standardisés après un dépistage ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les traitements sont personnalisés selon le patient et les maladies détectées."
}
},
{
"@type": "Question",
"name": "Le dépistage multiple peut-il réduire les coûts de traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut réduire les coûts en évitant des traitements tardifs et des complications."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir sans dépistage ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Sans dépistage, des maladies peuvent progresser, entraînant des complications graves."
}
},
{
"@type": "Question",
"name": "Le dépistage multiple peut-il réduire les complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il permet de traiter les maladies avant qu'elles ne causent des complications."
}
},
{
"@type": "Question",
"name": "Quelles complications sont souvent évitées par le dépistage ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme les maladies cardiaques ou certains cancers peuvent être évitées."
}
},
{
"@type": "Question",
"name": "Le dépistage multiple peut-il entraîner des complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans de rares cas, des faux positifs peuvent entraîner des traitements inutiles et des complications."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications après un dépistage ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et des ajustements de traitement sont essentiels pour gérer les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour le dépistage multiple ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, l'âge avancé et les habitudes de vie sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Comment les facteurs de risque influencent-ils le dépistage ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils déterminent la nécessité et la fréquence des tests de dépistage recommandés."
}
},
{
"@type": "Question",
"name": "Les facteurs de risque sont-ils les mêmes pour tous ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils varient selon les populations et les maladies ciblées par le dépistage."
}
},
{
"@type": "Question",
"name": "Peut-on modifier les facteurs de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des changements de mode de vie peuvent réduire certains facteurs de risque, comme l'obésité."
}
},
{
"@type": "Question",
"name": "Comment évaluer ses facteurs de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un bilan de santé régulier et des consultations médicales aident à évaluer les facteurs de risque."
}
}
]
}
]
}
In recent years, methicillin-resistant Staphylococcus aureus (MRSA) orbital cellulitis (OC) has drawn increasing clinical and public health concern. We present a case series of MRSA OC encountered at ...
A multi-centre retrospective case series investigating MRSA OC in Australia from 2013 to 2022. Patients of all ages were included....
Nine cases of culture-positive non-multi-resistant MRSA (nmMRSA) OC were identified at four tertiary institutions across Australia (7 male, 2 female). Mean age was 17.1 ± 16.7 years (range 13-days to ...
NMMRSA OC can follow an aggressive clinical course causing severe orbital and intracranial complications across a wide demographic. However, early recognition, initiation of targeted antibiotics and s...
Methicillin-resistant Staphylococcus aureus (MRSA) has an increasing prevalence of multi-drug resistance. There is an urgent need for developing novel approaches to combat MRSA infection. Mucosal pent...
This study aims to identify risk factors associated with Methicillin-resistant Staphylococcus aureus (MRSA) infection in children diagnosed with acute osteomyelitis (AO) and to elucidate the laborator...
We conducted a retrospective analysis involving 123 children with acute osteomyelitis treated at our hospital. Upon admission, we measured white blood cell (WBC) counts, C-reactive protein (CRP) level...
The MRSA group had a significantly higher average age compared to the non-MRSA group (P < 0.05). Notably, the incidence of suppurative arthritis was significantly lower in the MRSA group (P < 0.05). A...
In children newly admitted with acute osteomyelitis, a CRP level exceeding 73.23 µg/mL may indicate a high likelihood of MRSA infection. For children with AO who have been hospitalized for three days ...
The objectives of this work were to know the prevalence of methicillin-resistant S. aureus (MRSA) infections in the paediatric population of our health department, to describe the risk factors for inf...
A retrospective, descriptive and analytical study of infections produced by MRSA versus those produced by MSSA was carried out during the years 2014 to 2018. Risk factors for MRSA infection were studi...
162 patients with S. aureus infections were identified. Of these, 25 (15.4%) were MRSA. The highest percentages of MRSA infection occurred among children who required hospital admission (23.4%). In th...
Our results suggest the need to review empirical local treatment regimen using drugs active against MRSA in infections of probable staphylococcal origin admitted to the hospital, especially if they ha...
The preferred antibiotic salvage regimen for persistent methicillin-resistant Staphylococcus aureus bacteremia (MRSAB) is unclear. We sought to evaluate the effectiveness and safety of vancomycin plus...
Single-center, retrospective cohort study between January 1, 2016, and December 31, 2021....
State University of New York Upstate University Hospital, a 748-bed tertiary care, academic medical center in Syracuse, NY....
Adult patients were included if they had blood cultures positive for MRSA ≥72 h, received vancomycin monotherapy initially, and received vancomycin plus ceftaroline for ≥24 h. Patients were excluded i...
Patients were medically complex with a median Pitt bacteremia score of 3, 63.3% (19/30) were admitted to the intensive care unit, and 66.7% (20/30) had infective endocarditis. Vancomycin-associated ac...
Vancomycin plus ceftaroline may represent an effective and well-tolerated salvage regimen option for persistent MRSAB....
Staphylococcus aureus is a common germ in bacterial infections in children. The rate of methicillin-resistant S. aureus (MRSA) is increasing lately....
The main aim is to know the rate of positive cultures to MRSA in Spanish pediatric emergency departments. The secondary aims are to analyse the risk factors for MRSA isolation (patient origin, history...
Retrospective multicenter study (07/01/2017-06/30/2018) with review of patient histories with isolation of S. aureus in samples of any origin obtained in 8 pediatric emergency departments of the Infec...
During this period, S. aureus was detected in 403 patients (average age 75.8 ± 59.2 months; 54.8% male): 28.8% hospital-related infections (HRI) and 71.2% community-related infections (CRI). Overall, ...
The overall MRSA rate was one in 6 staphylococcal infections. Higher MRSA rates were detected in samples of suppurating skin injuries and in foreign children or in children with a history of previous ...
We aimed to determine the synergistic effects of ceftaroline (CPT) in combination with daptomycin (DAP), vancomycin (VAN), or linezolid (LNZ) against various methicillin-resistant Staphylococcus aureu...
MRSA strains randomly selected from 2014 to 2018 were studied. Checkerboard titration and in vitro time-kill analyses were used to determine the synergistic activities of the antibiotic combinations....
A total of 10 genetically distinct MRSA strains were included in this study. The checkerboard titration analysis revealed that the CPT-DAP, CPT-VAN, and CPT-LNZ combinations had a synergistic effect a...
The CPT-DAP combination showed better synergistic activity than the CPT-VAN and CPT-LNZ combinations against the enrolled MRSA strains. DAP, rather than VAN or LNZ, might be a better choice for CPT co...
The methicillin-resistant Staphylococcus aureus (MRSA) polymerase chain reaction (PCR) has a high negative predictive value (NPV). We aimed to understand if there was a difference in the NPV of the MR...
We performed a single-center, retrospective cohort study of adults with a positive respiratory culture and MRSA nasal PCR admitted to a surgical ICU from 2016 to 2019. Patients were stratified by surg...
We analyzed 61 patients: 42.6% (n = 26) ACS-ICU and 57.4% (n = 35) CVICU. There were no differences in age, comorbidities, prior MRSA infection, recent antibiotic use, immunocompromised status, or ren...
The MRSA nasal PCR screen has a high NPV for ruling out MRSA pneumonia in critically ill surgical patients. However, patients in the CVICU and patients hospitalized ≥5 d had a longer time to de-escala...
Severe infections of virulent methicillin-resistant Staphylococcus aureus (MRSA) are a serious health problem. The present study aimed to investigate clonal spread, virulence and antimicrobial resista...
Molecular identification and mecA gene detection were performed with PCR. Clonal relatedness was evaluated by RAPD PCR and MLST. MRSA epidemiology, virulence and resistance patterns were investigated ...
All 27 isolates were identified as S. aureus and were mecA positive, and all were susceptible to linezolid, tigecycline and vancomycin. The toxin genes hlg (in 92.6% of isolates), seb (77.8%), sei (77...
To the best of our knowledge, this study is the first describing the clonal spreading of Bulgarian MRSA and the association with their virulence and resistance determinants. Monitoring of MRSA epidemi...
Endoscopic endonasal approach (EEA) procedures are inherently contaminated due to direct access through the nasopharyngeal mucosa. The reported rate of postoperative meningitis in EEA procedures is 0....
All adult patients who underwent EEA resection at our institution from 2013 to 2021 were retrospectively reviewed. Patients with preoperative cerebrospinal fluid infections were excluded. Data includi...
Of 483 patients identified (mean age, 51 years; range, 18-90 years; 274 [56.7%] female), 80 (16.6%) had a positive preoperative methicillin-resistant Staphylococcus aureus (MRSA)/methicillin-sensitive...
Postoperative rates of meningitis after EEA surgery were not significantly changed based on MRSA/MSSA colonization status of the patient or preoperative decolonization. The utility of preoperative tes...